(Reuters) — A California jury yesterday cleared former Chicago Bears wide receiver Willie Gault of intentionally defrauding investors in a scheme to inflate the price of stock in the heart-monitoring device company Heart Tronics.
The jury’s verdict found Gault, 54, not liable on 4 serious civil fraud charges, including intent to defraud and aiding and abetting fraud.
The jury did find he was liable for 3 other less serious charges, including charges that he violated provisions in the 2002 Sarbanes-Oxley law by filing false certifications in connection with the company’s financial statements.
"Mr. Gault entered the courtroom today with the shroud of serious securities fraud violations hanging over his head, and he exited the courtroom cleared of any serious misconduct and with the equivalent of a securities parking ticket," said his attorney George B. Newhouse Jr., a partner at Dentons.
The verdict comes more than 3 years after the U.S. Securities and Exchange Commission first filed its case against Gault, who previously served as Heart Tronics’ co-CEO, and several other former company executives.
The SEC’s case centered primarily on the actions of Mitchell Stein, the company’s outside counsel, whom the SEC alleged was orchestrating fictitious sales orders for the company’s products to pump up the stock price, selling the shares without disclosing it, and using the proceeds to fund a lavish lifestyle.
Stein was convicted of securities fraud in 2013 in a parallel criminal case, and was later sentenced to 17 years in prison.
The SEC had claimed that Stein brought in Gault as a figurehead of the company to take advantage of his celebrity status and make Heart Tronics seem successful.
Gault played 11 season in the National Football League, winning the Super Bowl with the Chicago Bears in 1985. He was also a member of the U.S. Olympic team that boycotted the 1980 Moscow Games.
The SEC said that Gault, as well as the company’s former CEO J. Rowland Perkins II, failed to question Stein’s conduct and did not meet their fiduciary duties to shareholders.
Last fall, Perkins settled charges that he had signed and certified three quarterly reports with materially false statements about the company’s sale orders, and agreed to pay a $42,500 penalty. He did not admit nor deny the allegations.
Andrew Ceresney, the head of the SEC’s enforcement division, said yesterday that the agency is "pleased" with the verdict in Gault’s case.
"As proved at trial, as CEO of a public company, Willie Gault filed false certifications with the SEC and knowingly circumvented the company’s internal controls," he said in a statement.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.